Harvard biotech wiz Greg Verdine grabs a $55M A round to build a groundbreaking biotech
It’s hard not to enjoy talking with Greg Verdine about the new biotech companies he sets up. Years of teaching at Harvard have honed his …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
